- Home
- VRCA
as 05-30-2025 4:00pm EST
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | WEST CHESTER |
| Market Cap: | 43.0M | IPO Year: | 2018 |
| Target Price: | $6.00 | AVG Volume (30 days): | 263.8K |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.38 - $9.36 | Next Earning Date: | 05-13-2025 |
| Revenue: | $7,179,000 | Revenue Growth: | -19.45% |
| Revenue Growth (this year): | 127.85% | Revenue Growth (next year): | 105.09% |
Stock Insider Trading Activity of Verrica Pharmaceuticals Inc. (VRCA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hayes Christopher G. | VRCA | CHIEF LEGAL OFFICER | Mar 14 '25 | Sell | $0.65 | 4,315 | $2,804.75 | 176,458 |
Latest Verrica Pharmaceuticals Inc. News
VRCA Breaking Stock News: Dive into VRCA Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
Thomson Reuters StreetEvents
18 days ago
Q1 2025 Verrica Pharmaceuticals Inc Earnings Call
GuruFocus.com
18 days ago
Verrica Pharmaceuticals Inc (VRCA) Q1 2025 Earnings Call Highlights: Strong YCANTH Demand and ...
Zacks
18 days ago
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
GlobeNewswire
18 days ago
Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results
Zacks
19 days ago
Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates
GuruFocus.com
20 days ago
Earnings To Watch: Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2025 Result
GlobeNewswire
25 days ago
Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025
Compare VRCA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VRCA Verrica Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.